The Goal – Advance Personalized Medicine BioVariance GmbH focuses together with a global player from the pharmaceutical industry on advancing research in personalized medicine. Due to the outstanding cooperation and the excellent expertise of both
Due to the rapid development of bioanalytical high-throughput technologies, such as NGS or HPLC/UPLC-MS, it became easy to generate complex data in record time. To answer research questions adequately, it is of utmost importance to
The global SARS-CoV-2 pandemic is an emerging, rapidly evolving situation. Therefore, increasing the test capacity to detect a virus infection is of utmost importance. BioVariance GmbH helped to fortify the regulatory submission proposal of a
Waldsassen – BioVariance finishes the development of TubeLab, a software for the organisation of multi-level laboratory processes. To ensure an effective performance of the workflow, TubeLab was developed in cooperation with a renowned diagnostics laboratory.
Waldsassen – BioVariance has finished the development of the platform OncoVariant for the interpretation of genetic variants in cancer patients. Thereby, the crucial search for suitable drugs is simplified and accelerated significantly. „Using OncoVariant, the oncologist
The facts „Colorectal carcinoma“ means several malignant tumor types in the colon or rectum. Malignant tumors rarely occur in other intestinal areas like small intestine or caecum. [1] Colorectal cancer (CRC) had a low incidence
The problem Generally, drugs are only allowed to be prescribed when special agencies have tested them on safety, effectiveness and quality and have approved them on corresponding indications. The prescription of drugs without considering these
Waldsassen – BioVariance has received a commitment for the project REVERT from the European Commission as part of HORIZON 2020, the EU framework program for research and innovation. The project goal is to identify the
World Cancer Day Many people wonder why there is still no cure for cancer yet. But cancer isn’t just one disease. It is more than 100 diseases, and each of these types is divided into
Technological progress The rapid advances in cutting-edge technologies and informatics tools utilized in biomedical science to generate and process high-throughput biological datasets have finally spread into various economic sectors. Omic technologies adopt a holistic view
Latest posts:
Categories:
How to find us
Follow us
How to find us
Follow us
We use cookie-free web analytics (Matomo). Information and an opt-out option can be found here.
